Chapter 12 Enzyme Inhibitors Produced by Microorganisms

Separation Methods for Antimicrobials, Antivirals and Enzyme Inhibitors - Journal of Chromatography Library ◽

10.1016/s0301-4770(08)60403-0 ◽

1989 ◽

pp. 481-538 ◽

Author(s):

Hamao Umezawa

Keyword(s):

Enzyme Inhibitors

Download Full-text

3644 Pleiotropic effect of angiotensin-converting enzyme inhibitors on MMP-9: a key enzyme in cardiac and vascular remodelling

European Heart Journal ◽

10.1016/s0195-668x(03)96228-2 ◽

2003 ◽

Vol 24 (5) ◽

pp. 711

Author(s):

D REINHARDT

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Pleiotropic Effect ◽

Converting Enzyme ◽

Vascular Remodelling ◽

Converting Enzyme Inhibitors ◽

Download Full-text

Irbesartan Combined With Conventional Therapy, Including Angiotensin Converting Enzyme Inhibitors, in Heart Failure

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)84523-8 ◽

1998 ◽

Vol 31 (2) ◽

pp. 188A ◽

Author(s):

M Tonkon

Keyword(s):

Heart Failure ◽

Angiotensin Converting Enzyme ◽

Conventional Therapy ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors

Download Full-text

Spectrophotometric Determination of Some Angiotensin Converting Enzyme Inhibitors By Potassium Dichromate and Potassium Permanganate in Tablet Dosage Form

Asian Journal of Biomedical and Pharmaceutical Sciences ◽

10.15272/ajbps.v4i39.642 ◽

2014 ◽

Vol 4 (39) ◽

pp. 16-24 ◽

Author(s):

Horria A. Mohamed

Keyword(s):

Angiotensin Converting Enzyme ◽

Potassium Permanganate ◽

Dosage Form ◽

Enzyme Inhibitors ◽

Potassium Dichromate ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

Download Full-text

Nephroprotective therapy with angiotensin converting enzyme inhibitors effect evaluation on the course of chronic kidney disease in children with urinary system congenital malformations

Nephrology (Saint-Petersburg) ◽

10.24884/1561-6274-2019-23-3-59-64 ◽

2019 ◽

Vol 23 (3) ◽

pp. 59-64

Author(s):

A. M. Mambetova ◽

A. M. Inarokova ◽

N. N. Shabalova ◽

D. V. Bizheva ◽

M. K. Mokaeva ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Angiotensin Converting Enzyme ◽

Congenital Malformations ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Urinary System ◽

Converting Enzyme ◽

Effect Evaluation ◽

Converting Enzyme Inhibitors

Download Full-text

Reactions induced by angiotensin-converting enzyme inhibitors – etiopathogenic, clinical and therapeutic aspects

Alergologia ◽

10.26416/aler.1.1.2017.1240 ◽

2017 ◽

Vol 1 (1) ◽

Author(s):

Polliana Mihaela Leru

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors

Download Full-text

Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin in chronic renal failure patients

MedPulse International Journal of Pharmacology ◽

10.26611/10101312 ◽

2020 ◽

Vol 13 (1) ◽

pp. 05-09

Author(s):

A Vinoth Kumar ◽

◽

P KalaiSelvi ◽

Keyword(s):

Renal Failure ◽

Chronic Renal Failure ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors

Download Full-text

Faculty Opinions recommendation of Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1090740.552962 ◽

2007 ◽

Author(s):

Carl Erik Mogensen

Keyword(s):

Kidney Disease ◽

Angiotensin Converting Enzyme ◽

Treatment Effects ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Urinary Protein Excretion ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

Protein Excretion ◽

Progression Risk

Download Full-text

Faculty Opinions recommendation of Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718386366.793501743 ◽

2014 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Cohort Study ◽

Coronary Artery ◽

Angiotensin Converting Enzyme ◽

Acute Coronary Syndromes ◽

Enzyme Inhibitors ◽

Beta Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

Coronary Syndromes

Download Full-text

Faculty Opinions recommendation of Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718408816.793497037 ◽

2014 ◽

Author(s):

Paul Savage

Keyword(s):

Enzyme Inhibitors ◽

Insulin Degrading Enzyme ◽

Degrading Enzyme

Download Full-text

Faculty Opinions recommendation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726264595.793522878 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Angiotensin Converting Enzyme ◽

Renal Dysfunction ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text